Results 211 to 220 of about 99,738,287 (255)

Advanced Glycation End Product Ligands for the Receptor for Advanced Glycation End Products: Biochemical Characterization and Formation Kinetics

open access: yesAnalytical Biochemistry, 2004
Advanced glycation end products (AGEs) accumulate with age and at an accelerated rate in diabetes. AGEs bind cell-surface receptors including the receptor for advanced glycation end products (RAGE). The dependence of RAGE binding on specific biochemical characteristics of AGEs is currently unknown.
Johan M Tekoppele   +2 more
exaly   +6 more sources

Advanced Glycation End Products and Its Receptor (RAGE) Are Increased in Patients With COPD

open access: yesRespiratory Medicine, 2011
SummaryAdvanced Glycation End products (AGEs) are the products of nonenzymatic glycation and oxidation of proteins and lipids. Formation of AGEs is increased in response to hyperglycaemia, reactive oxygen species and ageing.
Louise Nicholson, Peter Black, Lian Wu
exaly   +2 more sources

Effects of Atorvastatin on Serum Soluble Receptors for Advanced Glycation End-Products in Type 2 Diabetes

open access: yesAtherosclerosis, 2010
Objective: The receptor for advanced glycation end-products (RAGE) plays an important role in the pathogenesis of diabetic complications and atherosclerosis.
Kathryn Choon Beng Tan   +2 more
exaly   +2 more sources

Understanding RAGE, the receptor for advanced glycation end products

Journal of Molecular Medicine, 2005
Advanced glycation end products (AGEs), S100/calgranulins, HMGB1-proteins, amyloid-beta peptides, and the family of beta-sheet fibrils have been shown to contribute to a number of chronic diseases such as diabetes, amyloidoses, inflammatory conditions, and tumors by promoting cellular dysfunction via binding to cellular surface receptors.
Angelika, Bierhaus   +7 more
openaire   +2 more sources

Receptor for advanced glycation end-products in neurodegenerative diseases

Reviews in the Neurosciences, 2015
AbstractThis review, for the first time, aims to summarize the current knowledge in the emerging field of RAGE (receptor for advanced glycation end-products) studies in neurodegeneration and neurodegenerative diseases. RAGE, a member of the multiligand cell surface immunoglobulin family, has been implicated in numerous pathological conditions – from ...
Judyta Juranek   +3 more
openaire   +2 more sources

Advanced glycation end products, their receptors and diabetic angiopathy

Journal of the Peripheral Nervous System, 2002
The role of chronic hyperglycemia in the development of diabetic microvascular complications and in neuropathy has been clearly established by intervention studies. However, the biochemical or cellular links between elevated blood glucose levels, and the vascular lesions remain incompletely understood.
J L, Wautier, P J, Guillausseau
openaire   +2 more sources

Expression of advanced glycation end‐product receptors in the cochlea

The Laryngoscope, 2010
AbstractObjectives/Hypothesis:Advanced glycation end products (AGE) have recently been implicated in aging changes within different tissues of the body. The role of AGEs and their receptors in the mammalian inner ear is largely unknown. In this study we analyzed for the expression of two AGE receptors, namely RAGE and Ddost (AGE‐R1).Study Design ...
Hanusek, Claudia   +5 more
openaire   +3 more sources

Scavenger Receptors that Recognize Advanced Glycation End Products

Trends in Cardiovascular Medicine, 2002
Scavenger receptors recognize modified low-density lipoproteins (LDLs) such as acetylated LDL and oxidized LDL. Advanced glycation end products (AGE), which are generated through long-term exposure of proteins to glucose, also behave as active ligands for some scavenger receptors, including class A scavenger receptor (SR-A) and class B scavenger ...
Akira, Miyazaki   +2 more
openaire   +2 more sources

Receptor for Advanced Glycation End Products: Dementia and Cognitive Impairment

Drug Research, 2023
AbstractThe pathophysiological processes of dementia and cognitive impairment are linked to advanced glycation end products (AGEs) and their receptor (RAGE).The neurofibrillary tangles (NFTs) of abnormally hyperphosphorylated tau protein and senile plaques (SPs), which are brought on by ...
Aditya, Singh   +7 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy